U.S. Markets closed

Takeda forecasts operating loss as Shire integration costs mount

Daniel Shane in Hong Kong

Takeda said it expects to post a significant operating loss in its coming financial year as a result of integration costs associated with its £46bn deal to buy Shire. The Japanese drugmaker forecast on ...